These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34355567)

  • 1. 2-Mercaptomethyl Thiazolidines (MMTZs) Inhibit All Metallo-β-Lactamase Classes by Maintaining a Conserved Binding Mode.
    Hinchliffe P; Moreno DM; Rossi MA; Mojica MF; Martinez V; Villamil V; Spellberg B; Drusano GL; Banchio C; Mahler G; Bonomo RA; Vila AJ; Spencer J
    ACS Infect Dis; 2021 Sep; 7(9):2697-2706. PubMed ID: 34355567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.
    Hinchliffe P; González MM; Mojica MF; González JM; Castillo V; Saiz C; Kosmopoulou M; Tooke CL; Llarrull LI; Mahler G; Bonomo RA; Vila AJ; Spencer J
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3745-54. PubMed ID: 27303030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Mercaptomethyl-thiazolidines use conserved aromatic-S interactions to achieve broad-range inhibition of metallo-β-lactamases.
    Rossi MA; Martinez V; Hinchliffe P; Mojica MF; Castillo V; Moreno DM; Smith R; Spellberg B; Drusano GL; Banchio C; Bonomo RA; Spencer J; Vila AJ; Mahler G
    Chem Sci; 2021 Jan; 12(8):2898-2908. PubMed ID: 34164056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Amino-2-Sulfanylbenzoic Acid as a Potent Subclass B3 Metallo-β-Lactamase-Specific Inhibitor Applicable for Distinguishing Metallo-β-Lactamase Subclasses.
    Wachino JI; Kanechi R; Nishino E; Mochizuki M; Jin W; Kimura K; Kurosaki H; Arakawa Y
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products.
    Hinchliffe P; Calvopiña K; Rabe P; Mojica MF; Schofield CJ; Dmitrienko GI; Bonomo RA; Vila AJ; Spencer J
    J Biol Chem; 2023 May; 299(5):104606. PubMed ID: 36924941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
    Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
    J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic Boronates Inhibit All Classes of β-Lactamases.
    Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Insights for Core Scaffold and Substrate Specificity of B1, B2, and B3 Metallo-β-Lactamases.
    Yun Y; Han S; Park YS; Park H; Kim D; Kim Y; Kwon Y; Kim S; Lee JH; Jeon JH; Lee SH; Kang LW
    Front Microbiol; 2021; 12():752535. PubMed ID: 35095785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors.
    Cain R; Brem J; Zollman D; McDonough MA; Johnson RM; Spencer J; Makena A; Abboud MI; Cahill S; Lee SY; McHugh PJ; Schofield CJ; Fishwick CWG
    J Med Chem; 2018 Feb; 61(3):1255-1260. PubMed ID: 29271657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiscale approach to predict the binding mode of metallo beta-lactamase inhibitors.
    Gervasoni S; Spencer J; Hinchliffe P; Pedretti A; Vairoletti F; Mahler G; Mulholland AJ
    Proteins; 2022 Feb; 90(2):372-384. PubMed ID: 34455628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of β-Lactam Resistance by Aspergillomarasmine A Is Influenced by both the Metallo-β-Lactamase Target and the Antibiotic Partner.
    Rotondo CM; Sychantha D; Koteva K; Wright GD
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of Metallo-β-lactamase Inhibition by
    Farley AJM; Ermolovich Y; Calvopiña K; Rabe P; Panduwawala T; Brem J; Björkling F; Schofield CJ
    ACS Infect Dis; 2021 Jun; 7(6):1809-1817. PubMed ID: 34003651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.
    Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the mobile metallo-β-lactamase AIM-1 from Pseudomonas aeruginosa: insights into antibiotic binding and the role of Gln157.
    Leiros HK; Borra PS; Brandsdal BO; Edvardsen KS; Spencer J; Walsh TR; Samuelsen O
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4341-53. PubMed ID: 22664968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive screening of marine metabolites against class B1 metallo-β-lactamases of
    Diaz A; G S; Balaji S; Ramakrishnan J; Thamotharan S; Ramakrishnan V
    J Biomol Struct Dyn; 2023 Dec; 41(20):10930-10943. PubMed ID: 36541935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Peptide-based Metallo-β-lactamase Inhibitors as a New Strategy to Combat Antimicrobial Resistance: A Mini-review.
    Cheng Q; Zeng P; Chi Chan EW; Chen S
    Curr Pharm Des; 2022; 28(44):3538-3545. PubMed ID: 36177630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.
    Gavara L; Sevaille L; De Luca F; Mercuri P; Bebrone C; Feller G; Legru A; Cerboni G; Tanfoni S; Baud D; Cutolo G; Bestgen B; Chelini G; Verdirosa F; Sannio F; Pozzi C; Benvenuti M; Kwapien K; Fischer M; Becker K; Frère JM; Mangani S; Gresh N; Berthomieu D; Galleni M; Docquier JD; Hernandez JF
    Eur J Med Chem; 2020 Dec; 208():112720. PubMed ID: 32937203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens
    Samuelsen Ø; Åstrand OAH; Fröhlich C; Heikal A; Skagseth S; Carlsen TJO; Leiros HS; Bayer A; Schnaars C; Kildahl-Andersen G; Lauksund S; Finke S; Huber S; Gjøen T; Andresen AMS; Økstad OA; Rongved P
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.
    Brem J; van Berkel SS; Zollman D; Lee SY; Gileadi O; McHugh PJ; Walsh TR; McDonough MA; Schofield CJ
    Antimicrob Agents Chemother; 2016 Jan; 60(1):142-50. PubMed ID: 26482303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.